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Abstract The functional shift of quiescent endothelial
cells into tip cells that migrate and stalk cells that prolif-
erate is a key event during sprouting angiogenesis. We
previously showed that the sialomucin CD34 is expressed
in a small subset of cultured endothelial cells and that these
cells extend ﬁlopodia: a hallmark of tip cells in vivo. In the
present study, we characterized endothelial cells expressing
CD34 in endothelial monolayers in vitro. We found that
CD34-positive human umbilical vein endothelial cells
show low proliferation activity and increased mRNA
expression of all known tip cell markers, as compared to
CD34-negative cells. Genome-wide mRNA proﬁling
analysis of CD34-positive endothelial cells demonstrated
enrichment for biological functions related to angiogenesis
and migration, whereas CD34-negative cells were enriched
for functions related to proliferation. In addition, we found
an increase or decrease of CD34-positive cells in vitro
upon exposure to stimuli that enhance or limit the number
of tip cells in vivo, respectively. Our ﬁndings suggest cells
with virtually all known properties of tip cells are present
in vascular endothelial cell cultures and that they can be
isolated based on expression of CD34. This novel strategy
may open alternative avenues for future studies of molec-
ular processes and functions in tip cells in angiogenesis.
Keywords Angiogenesis  Endothelial tip cell  Vascular
endothelial cell cultures  CD34
Introduction
Angiogenesis is crucial in the pathogenesis of many chronic
and potentially fatal diseases [1, 2]. In order to promote
vascular network expansion, sprouting angiogenesis
requires a subset of specialized endothelial cells while the
majority of cells remains quiescent in the pre-existing blood
vessel. Among these highly specialized cells are tip cells,
which coordinate multiple critical processes in a hierar-
chical way. Located at the leading edge of the vascular
sprout, tip cells form cellular protrusions or ﬁlopodia to
guide migration towards a source of angiogenic growth
factors [3]. Simultaneously, they signal to adjacent endo-
thelial cells via Delta-like ligand (DLL)-Notch interactions
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DOI 10.1007/s10456-011-9251-znot to adapt the tip cell phenotype, but to maintain the
proliferative stalk cell phenotype and to form a vascular
lumen [3, 4]. Because tip cells comprise a distinct sub-
population of endothelial cells with a unique molecular
signature, they constitute an attractive target for pro- and
anti-angiogenic therapy. Yet to develop such therapeutic
strategies, a thorough understanding of the regulation of tip
cell functions and the genes involved is needed.
Research on tip cells predominantly relies on in vivo
models of angiogenesis [3–11], especially on develop-
mental retinal angiogenesis during the ﬁrst postnatal week
in mice. These studies have shown that the fate of endo-
thelial tip cells is controlled by a number of different sig-
naling pathways, including that of vascular endothelial
growth factor (VEGF) [2, 3, 9, 11] and the Notch ligand
DLL4 [4]. In vitro tests can provide critical information on
many factors regulating angiogenesis in vivo and are
essential ﬁrst steps for preclinical validation of potential
therapeutic targets. Whether the tip cell phenotype is
present in 2-dimensional vascular endothelial cell cultures,
and whether this subpopulation of cells can be isolated is
experimentally unexplored.
We hypothesized that, within the context of vascular
endothelialcellcultures,CD34isanovelmarkertoselectfor
endothelial cells witha tip cell phenotype in vitro. CD34 isa
highly glycosylated transmembrane cell surface glycopro-
tein, expressed by hematopoietic stem and progenitor cells
[12–14] and, on the luminal cell membrane of quiescent
endothelial cells of small blood vessels and lymphatics
[7, 15–20]. Consequently, freshly-isolated human vascular
endothelialcellsareCD34-positive(CD34
?),butexpression
is rapidly lost when resting cells are cultured and forced into
cell cycle [21, 22]. Interestingly, a small subset of CD34
?
cellsremainspresentinlaterpassagesofprimaryendothelial
cell cultures and also in immortalized endothelial cell lines
[23]. In human umbilical vein endothelial cell (HUVEC)
cultures, we previously observed that these CD34
? cells
extendﬁlopodia[7].CD34expressiononendothelialtipcell
ﬁlopodia was also detected during angiogenesis in human
tumorsandembryogenesis,andinmouseembryogenesisand
wound healing [7, 19, 20].
Inordertofurtherunravelthemolecularmechanismsthat
induce and maintain tip cell identity and regulate their
speciﬁc functions, we investigated these CD34
? cells in
cultures of vascular endothelial cells. We show that this
CD34
?-subset of endothelial cells have ﬁlopodia, low pro-
liferation activity and that the CD34
? phenotype in endo-
thelialcellculturesisregulatedsimilarlytomechanismsthat
regulatethetipcellphenotypeinvivo.Weexploitedpositive
selection of CD34
? vascular endothelial cells in vitro and
compared their transcriptome to CD34-negative (CD34
-)
cells. Real-timePCRandmicroarray data analysisidentiﬁed
increased expression of all known genes previously
associated with tip cells in vivo. Our results open alternative
avenues of research that may help to understand the molec-
ular processes and functions in angiogenesis in general, and
of the specialized endothelial tip cell in particular.
Materials and methods
Cells and cell cultures
Primary HUVECs were isolated from umbilical veins by
collagenase digestion according to a published method [24]
and routinely grown in M199 basal medium (Gibco, Grand
Island, NY, USA) supplemented with 10% human serum,
10% fetal bovine serum (Biowhittaker, Walkersville, MD,
USA) and 1% penicillin-streptomycin-glutamine (Gibco).
Umbilical cords were obtained from the Department of
Obstetrics and Gynaecology (Academic Medical Center,
Amsterdam, The Netherlands). HUVEC cultures between
passages 1 and 3 were used for all experiments. EC-RF24
[23] (derived from HUVECs) and HMEC-1 [23] (derived
from human dermal microvascular endothelial cells) were
routinely grown in EGM-2 MV BulletKit (Lonza, Walk-
ersville, MD, USA). EC-RF24 and HMEC-1 between
passages 30 and 40 were used for all experiments. All cells
were cultured in 0.2% gelatin-coated culture ﬂasks at
37C and 5% CO2. HMEC-1 was a kind gift of Prof.
Dr. P. Hordijk (Sanquin, Amsterdam, The Netherlands) and
EC-RF24 was a kind gift of A.M. Klous (Academic
Medical Center, Amsterdam, The Netherlands).
When indicated, cells were treated with VEGF (R&D
Systems, Minneapolis, MN, USA), basic ﬁbroblast growth
factor (bFGF) (Invitrogen, Carlsbad, CA, USA), or tumor
necrosis factor-alpha (TNF-a) (10 ng/ml; R&D Systems)
or tissue culture plates were coated with 0.2% gelatin (w/v)
in PBS containing DLL4 (1 lg/ml; R&D Systems) or
bovine serum albumin (Sigma-Aldrich, St Louis, MO,
USA) as a control according to Harrington et al. [25].
Immunostaining of cell cultures
For immunoﬂuorescence microscopy, third passage
HUVECs were grown to conﬂuence on gelatin-coated cov-
erslips (Thermo Scientiﬁc, South Logan, UT, USA). Cells
were ﬁxed for 20 min with freshly-prepared 2% parafor-
maldehyde in PBS and blocked for 30 min in 10% normal
goat serum in PBS at room temperature. For double immu-
nostaining, cells were incubated overnight at 4C with
antibodies directed against CD34 [7] (clone QBEND-10;
Monosan, Uden, The Netherlands) and cadherin 5 (CDH5;
alsoknownasvascularendothelialcadherin(VE-Cadherin))
(Abcam, Cambridge, UK). Secondary antibodies were goat
anti-mouse ﬂuorescein isothiocyanate (FITC) and goat
152 Angiogenesis (2012) 15:151–163
123anti-rabbit Cyanine-3 (Cy3) (Jackson Laboratories, Bar
Harbor, ME, USA). The coverslips were then mounted in
Vectashield (Vector Laboratories, Burlingame, CA, USA)
containing DAPI and examined using a wide-ﬁeld ﬂuores-
cence microscope (Leica, Heidelberg, Germany). As nega-
tive controls, primary antibody was omitted.
Immunohistochemistry of tissue samples
Vibratome sections from paraformaldehyde-ﬁxed normal
and pathologic human tissues were stained with anti-CD34
or anti-CD31 (clone EN4; Abcam) antibody as described
previously [7].
The spheroid-based angiogenesis model
HUVECs (750 cells/spheroid) were seeded in methyl cel-
lulose (Sigma-Aldrich) containing medium to form cell
spheroids (http://spherogenex.de)[ 26]. After 24 h, cells
were embedded in collagen gel with or without bFGF
(20 ng/ml, R&D Systems) and allowed to sprout for 24 h.
Gels containing the spheroids were ﬁxed with 2% para-
formaldehyde in PBS overnight and immunostained as
described above.
Flow cytometric analysis
Cell suspensions were obtained by TrypLE (Gibco) treat-
ment of adherent endothelial cell monolayers. All immu-
noﬂuorescent labeling and washing was performed in PBS
containing 0.1% bovine serum albumin. Cells were ﬁxed
in 2% paraformaldehyde in PBS for 15 min at room
temperature and incubated with anti-CD34-phycoerythrin
(anti-CD34-PE; clone QBend-10; Monosan), anti-CD31-
allophycocyanin (anti-CD31-APC; eBioscience, San
Diego, CA, USA), anti-CD146-FITC (Abcam), anti-CD14-
FITC (Becton Dickinson, Mountain View, CA, USA),
anti-CD133-APC (Miltenyi Biotec, Bergisch Gladbach,
Germany), and anti-CD117-APC (Becton Dickinson).
Cells were analyzed by ﬂow cytometry on a FACSCalibur
(Becton Dickinson) in combination with FlowJo software
(Tree Star, San Carlos, CA, USA).
Cell sorting and RNA isolation
HUVECs of passage 3 were sorted for CD34 expression at
3 9 10
7 cells/h under sterile conditions on a FACSAria
(Becton Dickinson) and total RNA from both fractions
(CD34
? and CD34
-) was extracted using TRIzol (Invit-
rogen). The amount of total RNA was approximately 1 lg/
10
5 cells, as measured on a nanodrop (ND-1000; NanoDrop
Technologies, Wilmington, DE, USA), and RNA quality
was determined by Bioanalyzer 2100 traces (Agilent
Technologies, Santa Clara, CA, USA) according to the
manufacturer’s protocols.
Quantitative PCR
A1 - lg aliquot of total RNA was DNase-I treated (ampli-
ﬁcation grade; Invitrogen) and reverse transcribed into
ﬁrst-strand cDNA using Superscript III and oligo(dT)12–18
(Invitrogen). Primer details are provided in Supplementary
Table 1. NCBI BLAST conﬁrmed speciﬁcity of the prim-
ers. The presence of a single PCR product was veriﬁed by
both the presence of a single melting temperature peak and
detection of a single band of the expected size on agarose
gels. Non-template controls were included to verify the
method and the speciﬁcity of the primers. Mean primer
efﬁciency was 96% ± 3%. Real-time quantitative PCR
(qPCR) was performed as described previously [27, 28],
using a CFX96 real-time PCR detection system (Bio-Rad
Laboratories, Hercules, CA, USA). Gene expression data
was normalized with the geomean of b-actin and tyrosine
3-monooxygenase/tryptophan 5-monooxygenase activation
protein, and zeta polypeptide (YWHAZ) gene expression
data, as determined by NormFinder [29].
Microarray analysis
TheGeneChipHTHG-U133?PMArrayPlate(Affymetrix,
Santa Clara, CA, USA) system was used for microarray
analysis. Technical handling of the microarrays was
performed at the MicroArray Department (MAD) at the
Swammerdam Institute for Life Sciences (University of
Amsterdam, Amsterdam, The Netherlands). In short, biotin-
labeled cRNA samples were prepared as described in the
GeneChip3’IVTexpresskitusermanual(Affymetrix)using
0.1 lg puriﬁed total RNA as template for the reaction and a
16 h incubation time. Hybridization, staining and scanning
were performed in a GeneTitan MC Instrument (Affyme-
trix). The raw data are available at the Gene Expression
Omnibus(GSE34850)(http://www.ncbi.nlm.nih.gov/geo/).
After passing array quality control, expression values for
each array were calculated using the robust multi-array
average (RMA) algorithm, (Affy package version 1.22.0)
[30] available from the Bioconductor project (http://
www.bioconductor.org) for the R statistical language
(http://cran.r-project.org). The normalized data was statis-
tically analyzed for differential gene expression using
ANOVA (Maanova package, version 1.14.0) [31] with a
modelthat consideredthe presence ofCD34as aﬁxed effect
and individual as a random effect. In order to quantify the
effect of the presence of CD34 on gene expression, a
permutation based statistical test (2,000 permutations) was
performed, and all P values were adjusted for false discov-
ery-rate correction [32]. Corrected Pvaluesof less than 0.15
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123were considered to indicate signiﬁcant differences. Model-
based log2 ratios of CD34
? signal to CD34
- signal were
generated for each probe set. A list was generated that con-
tained those probe sets for which an average absolute fold
change of at least 2.0 was observed between CD34
? and
CD34
- samples.
Gene ontology analysis and statistics
Geneontology(GO)termenrichmentwasperformedwiththe
twosetsthatwereC2-foldupregulatedordownregulatedwith
statisticalsigniﬁcance,usingtheDAVIDalgorithm[33]with
the total set of genes of the Affymetrix HG-U133A chip as
background. The following GO terms were selected: GO-
TERM_BP_ALL (biological process), GOTERM_CC_ALL
(cellular component) and GOTERM_MF_ALL (molecular
function), with classiﬁcation strategy ‘high’. GO terms were
assumedtobebiologicallyrelevantwithanenrichmentscore
ofatleast2.5andaBenjamini–Hochberg–correctedmodiﬁed
Fisher’sexactPvalueoflessthan0.02.Benjamini–Hochberg
statisticswereusedtocorrectPvaluetobemoreconservative
in order to lower family-wise false discovery rate [34].
Gene set enrichment analysis
Changesintheexpressionoffunctionallyrelatedgenesatthe
genome-wide expression proﬁle level were detected using
gene set enrichment analysis (GSEA) (version 2.07; Broad
Institute, Cambridge, MA, USA). For the analysis, genes
represented by more than one probe were collapsed to the
probe with the maximum valueusingthe gene symbols[35].
Gene sets were generated from gene lists published by
Strasser et al. [8], Del Toro et al. [5], and Harrington et al.
[25]. Mouse gene symbols were converted to their human
homologues (http://ncbi.nlm.nih.gov/homologene). Genes
of which no human homologue could be found were exclu-
ded from the list. In this way, ﬁve gene lists were generated
(1)Strasseretal.C2-foldoverrepresentedinamicrodisected
tip-cell fraction; (2) Del Toro et al. C2-fold upregulated
genes in dll4?/- mouse retina; (3) Del Toro et al. C2-fold
downregulated genes in dll4?/- mouse retina; (4) Har-
rington et al. C1.5-fold upregulated genes in DLL4-retro-
virally-infected HUVECs; (5) Harrington et al. C1.5-fold
downregulated genes in control empty vector-infected
HUVECs. Our data was then tested for enrichment in these
ﬁve gene sets usingGSEA, with the number ofpermutations
set to 1,000. False discovery rate (FDR) Q value\25% was
used as criteria for signiﬁcantly enriched gene sets.
Live cell imaging
Live cell imaging was performed according to a published
method [36]. In brief, equal yields of CD34
? and
CD34
-sorted HUVECs were seeded separately into a
6-well plate. After 12 h of incubation, the culture medium
above the cells was layered with mineral oil (Sigma-
Aldrich) to prevent evaporation of the medium. The 6-well
plate was placed at 37C in an atmosphere containing 5%
CO2 under an inverted microscope (Leica) and phase
contrast images were acquired at time intervals of 10 min
for 48 h at 10 ﬁxed spots in each cell culture. Time lapse
movies were analyzed using custom-made software.
Statistical analysis
All cell culture experiments were performed in triplicate.
Analysis of variance with signiﬁcance a = 0.05 was used
for processing the data. Statistical signiﬁcance was deter-
mined using a two-tailed Mann Whitney U test for qPCR
data or a (paired) Student t test for FACS and live cell
imaging data. Prism 5 software (GraphPad Software Inc,
San Diego, CA, USA) was used for statistical analysis.
Results
CD34 is expressed on ﬁlopodia of endothelial cells
in angiogenesis in vivo
Luminal endothelial CD34 staining was observed to be
ubiquitous in quiescent small blood vessels and capillaries
in non-pathologic human tissues. However, in human colon
carcinoma, in addition to the luminal endothelial mem-
brane staining, a striking CD34 staining of abluminal
ﬁlopodia was observed, extruding from endothelial cells at
sites of active angiogenesis (Fig. 1). In serial sections
Fig. 1 CD34 is expressed on endothelial ﬁlopodial extensions at sites
of active angiogenesis in vivo. Immunoperoxidase staining with anti-
CD34 monoclonal antibody QBEND-10 of a section of surgically
removed human colon carcinoma lesion. Anti-CD34 antibody stains
capillaries and numerous endothelial ﬁlopodia (arrowheads). 9450
154 Angiogenesis (2012) 15:151–163
123stained with anti-CD31 antibody, staining of ﬁlopodia was
not observed (data not shown).
Morphological characterization of CD34
? cells
in vascular endothelial cell cultures
Employing ﬂow cytometry, we found that the mean pro-
portion of CD34
? cells in HUVEC cultures from 5 dif-
ferent donors was 11.9% (SD 3.0; range 7.4–15.9%) at
passage 3 (Fig. 2a). To study the morphological charac-
teristics of the CD34
? HUVECs in vitro, we examined
HUVECs in a conﬂuent monolayer. Immunoﬂuorescence
microscopy showed a small fraction of CD34
? cells,
whereas the vascular endothelial cell marker VE-cadherin
was readily detectable in every cell (Fig. 2b). In the frac-
tion of HUVEC cells that expressed CD34, CD34 staining
was detected on all cell membrane domains, but these
CD34
? HUVEC cells had a distinct morphological
appearance. They were often elongated, and demonstrated
a polarized extension of CD34-marked ﬁlopodia located in
one or two areas of their plasma membrane (Fig. 2b).
These observations are in agreement with earlier reports
describing that CD34
? HUVECs have morphological
characteristics similar to tip cells in vivo, which have ﬁl-
opodia at the leading front of the cells [7].
To rule out the possibility that the CD34
? cells in
HUVEC cultures were contaminating hematopoietic stem/
progenitor cells and to conﬁrm the endothelial nature and
purity of cells, we showed co-expression of the endothelial
markers CD31, VE-cadherin and CD146, and excluded
expression of stem cell markers CD133 and CD117 and the
myelomonocytic marker CD14 (Fig. 3).
DAPI CD34 b DAPI VE-cadherin DAPI VE-cadherin CD34
H
U
V
E
C
PE
a
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S
C
CD34-PE antibody Negative control
0.07% 11.7%
Fig. 2 Morphology of CD34
? cells in HUVEC cultures shows a
strong resemblance with that described for tip cells in vivo. a Flow
cytometric dot plots of HUVECs of one representative donor
demonstrating the proportion of CD34
? cells in a HUVEC culture
at passage 3. b Third passage HUVECs expressed VE-cadherin (red),
but only a subset was stained for CD34 (green). Note ﬁlopodia
extending from elongated CD34
? HUVECs (arrowheads), whereas
adjacent CD34
- HUVECs show cobblestone morphology and lack of
ﬁlopodia. DNA was stained with DAPI (blue). (Color ﬁgure online)
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123CD34
? cells are actively generated in endothelial cell
cultures and show low proliferation activity
We investigated whether the CD34
? phenotype in culture
is reversible, as recent observations in vivo have demon-
strated that the positions and phenotypes of tip cells and
stalk cells in sprouting vessels are reversible [37]. We
found that CD34
- cells isolated from primary human
endothelial cells were able to re-express CD34 when these
cells were cultured again. After 10 days of culture, the
relative subpopulation of CD34
? cells was of a similar
magnitude compared to unsorted HUVECs (Fig. 4a, b).
Re-expression of CD34 in CD34
- FACS-sorted cell cul-
tures was also observed in 2 immortalized human endo-
thelial cell lines, HMEC-1 and ECRF24 (data not shown).
Tip cells in vivo have low proliferation activity [3]. To
further characterize the CD34
? cell population with respect
to proliferation activity, we sorted HUVECs by FACS,
C
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Fig. 3 CD34
? cells in HUVEC cultures co-express endothelial
markers. CD34
? HUVECs were analyzed by 2-color ﬂow cytometry
for the expression of CD31, CD146 and VE-cadherin (endothelial cell
speciﬁc markers), CD133 and CD117 (stem cell and endothelial
progenitor cell speciﬁc markers), and CD14 (myelomonocytic
speciﬁc marker). The results demonstrate that all CD34
? cells are
positive for CD31, CD146 and VE-cadherin, but negative for CD133,
CD117 and CD14
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123cultured CD34
? and CD34
- cells separately and analyzed
cell proliferation through live-cell imaging. CD34
?
HUVECs showed fewer cells in mitosis as compared to
CD34
- HUVECs (Fig. 4c, d). We detected no differences
in cell cycle time between CD34
? and CD34
- cells.
CD34
? phenotype in endothelial cell cultures is
regulated by similar mechanisms that regulate the tip
cell phenotype in vivo
Differentiation into the tip cell phenotype in vivo is con-
trolled by a number of signaling pathways, including that
of VEGF [2, 3, 38], TNF-a [39], and Notch ligand DLL4
[4]. In addition, binding of VEGF-A to VEGF receptor 2
(VEGFR2) in tip cells induces expression of DLL4, and
subsequently DLL4 binds to Notch that is expressed on
adjacent cells providing a signal inducing the stalk cell
phenotype [4]. We determined whether the relative amount
of CD34
? cells in vitro is also controlled by these 3
mechanisms. Third-passage HUVECs stimulated with
VEGF showed an increased percentage of CD34
? cells
whereas bFGF stimulation did not change the percentage of
CD34
? cells (Fig. 5a). For VEGF, the response was dose
dependent with a maximum effect at 25 ng/ml. HUVECs
continuously stimulated with TNF-a showed a reduced
number of CD34
? cells (Fig. 5b). In addition, we promoted
the stalk cell phenotype by activating Notch signaling by
culturing HUVECs on DLL4-coated dishes [25]. As pre-
dicted, this resulted in a decrease in the percentage of
CD34
? cells (Fig. 5c). However, the c-secretase inhibitor
DAPT, which inhibit Notch receptor cleavage and signal-
ing and leads to elevated numbers of tip cells in vivo [9],
did not increase the percentage of CD34
? cells when added
to HUVEC cultures.
Because monolayer HUVEC cultures may reﬂect only
certain aspects of the angiogenic cascade, we subsequently
studied CD34 expression on HUVEC in a 3-dimensional
spheroid-based tube formation model [26, 40, 41]. Before
embedding in collagen gel, HUVEC spheroids did not stain
with anti-CD34 antibody (data not shown). After
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Fig. 4 CD34
? cells in HUVEC cultures are actively generated and
show a lower proliferation rate. a CD34
- cells were sorted from
HUVEC cultures using FACS and then cultured again. b After
10 days of culture, cells were analyzed for CD34 expression by FACS
showing a subpopulation of 9.8% of CD34
? cells. SSC, side scatter.
CD34
? and CD34
- FACS-sorted HUVECs were cultured separately
for 48 h and images were taken every 15 min at 10 ﬁxed spots in each
culture. Time-lapse movies were analyzed by counting the total
amount of cells and the number of cells in mitosis, as recognized by
the division of one cell into 2 daughter cells. c Numbers of cells at the
given time points. d Total number of cells in mitosis. Shown are
means and standard error of the means (SEM); * indicates P\0.05,
relative to CD34
-, determined by Student t test
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123embedding in collagen gel containing FCS, only cells at the
surface of the spheroids re-expressed CD34 (Fig. 6). After
exposure to bFGF to induce sprouting angiogenesis, CD34
was expressed in the newly formed sprouts and on the
ﬁlopodial extensions of the leading tip cells (Fig. 6),
mimicking the expression pattern observed in angiogenesis
in vivo [7, 17, 19, 20].
Gene expression of tip cell markers is increased
in CD34
? endothelial cells in vitro
Besides expression of VEGFR2 and DLL4, other genes
have been associated with the tip cell phenotype in vivo,
including VEGFR3 [9, 11, 42], platelet-derived growth
factor B (PDGFB) [3], unc-5 homolog B (UNC5B) [43],
roundabout homologue 4 (ROBO4) [44], ephrin-B2
(EFNB2) [6, 10], and neuropilin-1 (NRP1) and NRP2 [45,
46]. Two more recent studies identiﬁed expression of
chemokine receptor type 4 (CXCR4), apelin (APLN), and
angiopoietin-2 (ANGPT2) to be enriched in tip cells [5, 8].
We analyzed the expression of these genes in FACS-sorted
CD34
? and CD34
- subpopulations of HUVECs by real-
time qPCR. mRNA expression levels of all 13 presently
known tip cell markers appeared to be increased in CD34
?
cells, and 9 out of 13 were signiﬁcantly (P\0.05) over-
expressed (more than 2-fold) as compared to CD34
- cells
(Table 1). We found a 121.8-fold overexpression of CD34
in CD34
? HUVECs, but no signiﬁcant changes in
expression levels of the other two CD34-family members
podocalyxin-like 1 (PODXL1) and PODXL2 (Supple-
mentary Table 2) [14].
CD34
? cells in HUVEC cultures are a model to study
tip cell phenotype and function in vitro
To further test our hypothesis that CD34 uniquely marks
endothelial cells with a tip-cell phenotype, and to further
characterize gene regulation in CD34
? HUVEC cells, we
performed Affymetrix cDNA microarray analysis in
CD34
? versus CD34
- cells. We found 441 genes to be
differentially expressed (more than 2-fold) with statistical
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Fig. 5 The number of CD34
? cells on HUVECs in vitro is regulated
by mechanisms known to induce or inhibit the tip cell phenotype in
vivo. The proportion of CD34
? HUVECs was determined by ﬂow
cytometry after culturing of cells in the presence or absence of VEGF,
bFGF, TNF-a or DLL4 for 48 h. a Dose-dependent increase of CD34
expressing cells when stimulated with VEGF but not bFGF.
b Continuous stimulation with TNF-a decreased the number of
CD34
? HUVECs. c HUVECs cultured on DLL4-coated plates
showed a lower number of CD34
? cells. Shown are mean and SD;
* indicates P\0.05 relative to control, determined by Student t test
for paired samples
DAPI DAPI CD34
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b
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Fig. 6 CD34 on HUVECs in vitro is upregulated during angiogenesis
and tip cell formation. 3-Dimensional in vitro angiogenesis of
collagen-gel embedded HUVEC spheroids cultured in the presence or
absence of bFGF after ﬁxation and staining for the expression of
CD34 (green). Arrowheads point at ﬁlopodial extensions of tip cells.
(Color ﬁgure online)
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123signiﬁcance (Q value \0.15), of which 172 were upregu-
lated and 269 downregulated in the CD34
? population
(Fig. 7a, Supplementary Table 3). The series of 172
upregulated genes was enriched for GO terms consistent
with the tip cell phenotype in vivo, such as angiogenesis,
regulation of cell migration and blood vessel morphogen-
esis (Fig. 7b). GO term analysis of the series of 269
downregulated genes showed enrichment for cell cycle
processes, an observation that is consistent with the absent
proliferation activity observed in tip cells (Fig. 7b) [3].
Transcriptional levels of a selection of over 25 differen-
tially expressed genes selected from the microarray data
were validated and conﬁrmed by qPCR in 7 HUVEC
donors sorted for CD34 (Supplementary Table 2). The
upregulated expression levels of known tip cell markers
were conﬁrmed in the microarray analysis, as 9 out of 13
were signiﬁcantly (Q value \0.15) overexpressed in
CD34
? HUVECs (Supplementary Table 2).
We examined whether our microarray data show overlap
with data of 2 microarray studies which investigated the tip
and stalk cell transcriptome in vivo but employed different
strategies [5, 8], and with a microarray study which
investigated the effects of DLL4-Notch signaling in
HUVECs [25]. GSEA showed that the gene sets positively
correlating with a tip cell phenotype were signiﬁcantly
enriched (P\0.05) in our CD34
? gene set, conﬁrming
that at least some of the genes that are upregulated in
CD34
? HUVECs in our study are potentially bone ﬁde tip
cell markers. The highest correlation (P\0.001) was
found with the gene set of Del Toro et al. [5], who com-
pared retinal endothelial cells isolated from the eyes of
Dll4?/- and wild type mice.
Among the genes that showed upregulated expression in
CD34
? HUVECs were the secreted molecules insulin
growth factor-2 (IGF2), insulin-like growth factor binding
protein 4 (IGFBP4) and adrenomedullin (Supplementary
Table 2). Furthermore, we found a marked upregulation of
CXCR4 and its ligand CXCL12 (also known as SDF-1)
(Supplementary Table 2).
Discussion
In this study, we demonstrate that cells with virtually all
the known properties of tip cells are present in 2-dimen-
sional vascular endothelial cell cultures and that they can
be isolated on the basis of CD34 expression. We found
CD34 expression in a subset of HUVEC, HMEC-1 and
ECRF24 cultures, in comparable numbers as observed in
previous studies [7, 22, 23]. We demonstrated that the
morphology of CD34
? cells in HUVEC cultures shows a
strong resemblance to the appearance of tip cells in human
tumors and developing mouse retina [3, 4, 6, 7, 9, 10]. Key
features of this similarity include their highly polarized
nature, numerous ﬁlopodia probing the environment, and
migration toward an angiogenic stimulus. Many in vivo
angiogenesis models rely on these typical morphological
aspects when studying tip cells, but to our knowledge, tip
cells have not previously been identiﬁed in endothelial
cultures in vitro.
We show that the percentage of cells expressing CD34
in endothelial cell monolayers in vitro appears to be reg-
ulated, at least partly, by similar mechanisms reported to
regulate the endothelial tip cell phenotype in vivo. These
ﬁndings strongly support our hypothesis that CD34
? cells
in vitro represent true tip cells. In fact, stimulation of
HUVECs with all three main known regulatory molecules
of the tip cell phenotype, i.e. VEGF [3], TNF-a [39], and
Notch ligand DLL4 [4], resulted in an increase or decrease
of CD34
? cells in HUVEC cultures as predicted by our
hypothesis. The maximum number of CD34
? cells that can
be generated in a HUVEC monolayer by adding VEGF
appeared to be limited in our model.
Both VEGF and bFGF are known to have potent
angiogenic activities in vivo and in vitro. We observed in
HUVEC monolayers that VEGF but not bFGF signaling
promotes the tip cell phenotype. Untreated HUVECs in
Table 1 qPCR analysis comparing CD34
? to CD34
- sorted
HUVECs revealed statistically signiﬁcant enriched expression of 9
genes previously identiﬁed as tip cell markers in vivo. In bold,
signiﬁcant change
Gene
symbol
Full name Mean fold difference
CD34
? compared to
CD34
- HUVEC
P value
VEGFR2 Kinase insert
domain receptor
5.9 0.002
VEGFR3 Fms-related
tyrosine kinase 4
1.8 0.180
NRP1 Neuropilin 1 2.5 0.013
NRP2 Neuropilin 2 4.8 0.003
PDGFB Platelet-derived
growth factor
beta polypeptide
2.1 0.180
DLL4 Delta-like 4 7.0 0.085
ANGPT2 Angiopoietin 2 8.1 0.004
APLN Apelin 5.0 0.025
UNC5B Unc-5 homolog B 4.1 0.475
ROBO4 Roundabout
homolog 4, magic
roundabout
2.0 0.013
PLXND1 Plexin D1 3.9 0.006
EFNB2 Ephrin-B2 4.4 0.009
CXCR4 Chemokine (C-X-C
motif) receptor 4
41.9 0.017
CD34 CD34 molecule 121.4 0.001
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123spheroids do not express CD34 [26, 40]. When we
embedded HUVEC spheroids in collagen gel-containing
FCS, CD34 expression was induced in endothelial cells at
the surface of the spheroid by both VEGF and bFGF.
Exposure to VEGF or bFGF induced three-dimensional in
vitro sprouting angiogenesis in this assay, with CD34
expression on tip cell ﬁlopodia. This demonstrates that the
tip cell phenotype and CD34 expression co-occur in angi-
ogenesis in vitro. Our ﬁndings suggest that bFGF signaling
alone stimulates angiogenesis but not necessarily the for-
mation of tip cells. These differences in the effects of
VEGF and bFGF stimulation in angiogenesis models in
two and three dimensions require further study.
By culturing the FACS sorted CD34
- and CD34
?
fractions of HUVECs, we found that the expression of
CD34 and maintenance of the CD34
? phenotype in vitro is
an active and reversible process. Our results further indi-
cate that formation of a subset of CD34
? cells in vitro is a
common feature of endothelial cell cultures, even in
immortalized cell lines after many passages. These ﬁndings
are in accordance with data from in vivo studies on tip
cells, which showed that tip cells are actively generated
and that a dynamic competition between endothelial cells
to become a tip cell occurs continuously [37]. It also shows
that in general, culture conditions employed in endothelial
cell cultures can be regarded as a pro-angiogenic
environment.
Comparison of isolated CD34
? and CD34
- HUVEC
populations showed increased gene expression of all
presently known tip cell markers in CD34
? cells by qPCR.
These results are again consistent with our hypothesis that
this CD34
? population represents tip cells in vitro.
Microarray analysis of the CD34
? and CD34
- HUVECs
further demonstrated that CD34
? cells display a gene
expression proﬁle that is consistent with a tip cell pheno-
type. CD34
? cells were enriched for genes associated with
biological functions such as ‘‘angiogenesis’’, ‘‘blood vessel
development’’ and ‘‘regulation of cell migration’’, and
CD34
- cells were enriched for genes associated with bio-
logical functions related to proliferation, including ‘‘cell
cycle process’’ and ‘‘mitosis’’. Furthermore, we found a
signiﬁcant correlation between our microarray analysis and
a
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Fig. 7 Gene expression proﬁles of CD34
? HUVECs show features of
a tip cell phenotype. a Pie chart (left) illustrating the number of genes
with signiﬁcantly (Q value \0.15) altered expression (total circle)
between CD34
? and CD34
- fractions, and the 441 genes with
signiﬁcantly (Q value [0.15) increased (yellow part) or decreased
(blue part) expression by more than 2-fold. Heat map (right) of the
441 differentially expressed genes in 4 HUVEC donors sorted for
CD34 (yellow, induced; blue, repressed; log2 based scale). b GO
analysis reveals a signiﬁcant association of CD34
? cells with terms
that are characteristic for tip cell functions and association of CD34
-
cells with terms of cell proliferation. P values represent a Benjamini–
Hochberg–corrected EASE score. (Color ﬁgure online)
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123three gene sets from recent studies that investigated
genomic proﬁles of vascular endothelial tip cells of various
sources [5, 8, 25].
Our microarray analysis of the tip cell transcriptome as
identiﬁed in CD34
? HUVECs has yielded a wealth of new
data. For example, inhibition of CXCR4 signaling was
recently shown by others to lead to defects in retinal tip cell
morphology and reduction of intercellular connections
between tip cells [8]. Our gene expression proﬁle of
CD34
? HUVECs conﬁrmed this association. We observed
co-expression of CXCL12 and CXCR4 which is consistent
with the recent evidence indicating that the CXCL12-
CXCR4 signaling axis has an important role in tip cell
formation and promotes an autocrine signaling mechanism
in endothelial tip cells [8]. The secreted molecules IGF2,
IGFBP4 and adrenomedullin were among the genes
upregulated in CD34
? HUVECs. Consistent with this
ﬁnding, secreted molecules also formed the largest cluster
of tip cell-enriched genes identiﬁed by del Toro et al. [5],
who suggested that these proteins are retained in the basal
lamina surrounding stalk cells following tip cell to stalk
cell transdifferentiation.
Our present study has characterized CD34
? cells in
HUVEC cultures and established an in vitro model for the
study of tip cell biology. Our results conﬁrmed previous
ﬁndings that CD34 is expressed in endothelial cell ﬁlopo-
dia at sites of active angiogenesis in vivo. We showed in
normal and pathological human tissues, in addition to the
overall luminal vascular staining, striking CD34 staining of
endothelial ﬁlopodial extensions at sites of active angio-
genesis in vivo. Our study did not aim at unraveling the
function of CD34 expression in tip cells. Recent evidence
has indicated that CD34 acts as an anti-adhesive molecule
during lumen formation in developing blood vessels,
by maintaining or promoting the separation between con-
tralateral apical endothelial cell surfaces in a luminal tube
[14, 47]. Although the function of CD34 in resting endo-
thelial cells and in tip cells during angiogenesis was not
addressed in the present study, we speculate that the pro-
posed anti-adhesive property of CD34 may also play a role
in maintaining vascular lumina in resting tissues, as well as
in allowing the migration of tip cells and the movement
and probing of their ﬁlopodia through the tissue matrix.
In summary, our ﬁndings suggest that the tip cell phe-
notype and CD34 expression co-occur in endothelial
monolayers in vitro. Our results show that these CD34
?
cells in vitro are a valid tip cell model and that differential
gene expression, functional characteristics and regulatory
mechanisms of these cells are likely to predict properties of
tip cells during angiogenesis. Along with the relative ease
to obtain vascular endothelial cell cultures, our model
allows for a convenient way to study effects of various
types of blockers or promoters on tip cell phenotype and tip
cell number. Furthermore, studies of the characteristics of
CD34
? cells in vascular endothelial cell cultures will open
new avenues for the study of molecular processes and
functions in angiogenesis in general, and of the specialized
endothelial tip cells in particular. By characterizing the
transcriptome of tip cells in vitro we have identiﬁed a large
number of tip cell-associated genes not previously pub-
lished, in addition to the known genes previously associ-
ated with tip cells in vivo. These ﬁndings expand the tip
cell gene expression proﬁle and may contribute signiﬁ-
cantly to our future understanding of tip cell biology and
angiogenesis.
Acknowledgments We thank Berend Hooibrink for assisting with
the FACS experiments; Maaike van Berkel for assisting with the
HUVEC spheroid angiogenesis model; and Jan Stap for help with the
live cell imaging. This work was partially funded by the Dutch
Association for the Prevention of Visually Impairment and Blindness,
the Blindenpenning Foundation, the Dr. F. P. Fisher foundation, the
Dutch National Foundation for the Visually Impaired and Blind, the
Dutch Oogfonds Foundation, the Dutch Macular Degeneration Fund,
and the Dutch Retina Foundation, combined in the Uitzicht grant
2009-18. The helpful editorial suggestions of Drs. Kelly McNagny
and Michael Hughes (The Biomedical Research Center, University of
British Columbia, Vancouver, BC, Canada) with respect to the
manuscript are gratefully acknowledged as well as the assistance in
the preparation of the ﬁnal version of the manuscript by Monique
Arendse.
Conﬂict of interest The authors declare no competing ﬁnancial
interests.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Hillen F, Grifﬁoen AW (2007) Tumour vascularization: sprouting
angiogenesis and beyond. Cancer Metastasis Rev 26(3–4):
489–502
2. Siemerink MJ, Augustin AJ, Schlingemann RO (2010) Mecha-
nisms of ocular angiogenesis and its molecular mediators. Dev
Ophthalmol 46:4–20
3. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A,
Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D,
Betsholtz C (2003) VEGF guides angiogenic sprouting utilizing
endothelial tip cell ﬁlopodia. J Cell Biol 161(6):1163–1177
4. Hellstrom M, Phng LK, Hofmann JJ, Wallgard E, Coultas L,
Lindblom P, Alva J, Nilsson AK, Karlsson L, Gaiano N, Yoon K,
Rossant J, Iruela-Arispe ML, Kalen M, Gerhardt H, Betsholtz C
(2007) Dll4 signalling through Notch1 regulates formation of tip
cells during angiogenesis. Nature 445(7129):776–780
5. del Toro R, Prahst C, Mathivet T, Siegfried G, Kaminker JS, Lar-
riveeB,BreantC,DuarteA,TakakuraN,FukamizuA,PenningerJ,
Eichmann A (2010) Identiﬁcation and functional analysis of
endothelial tip cell-enriched genes. Blood 116(19):4025–4033
6. Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu
ME, Acker T, Acker-Palmer A (2010) Ephrin-B2 regulates
Angiogenesis (2012) 15:151–163 161
123VEGFR2 function in developmental and tumour angiogenesis.
Nature 465(7297):487–491
7. Schlingemann RO, Rietveld FJR, Dewaal RMW, Bradley NJ,
Skene AI, Davies AJS, Greaves MF, Denekamp J, Ruiter DJ
(1990) Leukocyte antigen CD34 is expressed by a subset of
cultured endothelial cells and on endothelial abluminal micro-
processes in the tumor stroma. Lab Invest 62(6):690–696
8. Strasser GA, Kaminker JS, Tessier-Lavigne M (2010) Microarray
analysis of retinal endothelial tip cells identiﬁes CXCR4 as a
mediator of tip cell morphology and branching. Blood
115(24):5102–5110
9. Tammela T, Zarkada G, Wallgard E, Murtomaki A, Suchting S,
Wirzenius M, Waltari M, Hellstrom M, Schomber T, Peltonen R,
Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Yla-
Herttuala S, Shibuya M, Pytowski B, Eichmann A, Betsholtz C,
Alitalo K (2008) Blocking VEGFR3 suppresses angiogenic sprout-
ing and vascular network formation. Nature 454(7204):656–660
10. Wang YD, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek
ML, Sakakibara A, Adams S, Davy A, Deutsch U, Luthi U,
Barberis A, Benjamin LE, Makinen T, Nobes CD, Adams RH
(2010) Ephrin-B2 controls VEGF-induced angiogenesis and
lymphangiogenesis. Nature 465(7297):483–486
11. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO
(2003) Vascular endothelial growth factors and angiogenesis in
eye disease. Prog Retinal Eye Res 22(1):1–29
12. Andrews RG, Singer JW, Bernstein ID (1986) Monoclonal-anti-
body 12–8 recognizes A 115-Kd molecule present on both uni-
potent and multipotent hematopoietic colony-forming cells and
their precursors. Blood 67(3):842–845
13. Krause DS, Fackler MJ, Civin CI, May WS (1996) CD34:
structure, biology, and clinical utility. Blood 87(1):1–13
14. Nielsen JS, McNagny KM (2009) CD34 is a key regulator of
hematopoietic stem cell trafﬁcking to bone marrow and mast cell
progenitor trafﬁcking in the periphery. Microcirculation
16(6):487–496
15. Baumhueter S, Dybdal N, Kyle C, Lasky LA (1994) Global
vascular expression of murine CD34, a sialomucin-like endo-
thelial ligand for L-selectin. Blood 84(8):2554–2565
16. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P,
Delia D, Sutherland DR, Baker MA, Greaves MF (1990)
Expression of the CD34 gene in vascular endothelial cells. Blood
75(12):2417–2426
17. Lin GS, Finger E, Gutierrezramos JC (1995) Expression of CD34
in endothelial cells, hematopoietic progenitors and nervous cells
in fetal and adult-mouse tissues. Eur J Immunol 25(6):1508–1516
18. Ruiter DJ, Schlingemann RO, Rietveld FJR, Dewaal MT, Dewaal
RMW (1989) Monoclonal antibody-deﬁned human endothelial
antigens as vascular markers. J Invest Dermatol 93(2):25S–32S
19. Wood HB, May G, Healy L, Enver T, MorrissKay GM (1997)
CD34 expression patterns during early mouse development are
related to modes of blood vessel formation and reveal additional
sites of hematopoiesis. Blood 90(6):2300–2311
20. Young PE, Baumhueter S, Lasky LA (1995) The sialomucin
CD34 is expressed on hematopoietic cells and blood vessels
during murine development. Blood 85(1):96–105
21. Hellwig SMM, Damen CA, van Adrichem NPH, Blijham GH,
Groenewegen G, Grifﬁoen AW (1997) Endothelial CD34 is
suppressed in human malignancies: role of angiogenic factors.
Cancer Lett 120(2):203–211
22. Delia D, Lampugnani MG, Resnati M, Dejana E, Aiello A,
Fontanella E, Soligo D, Pierotti MA, Greaves MF (1993) CD34
expression is regulated reciprocally with adhesion molecules in
vascular endothelial cells in vitro. Blood 81(4):1001–1008
23. van Beijnum JR, van der Linden E, Grifﬁoen AW (2008)
Angiogenic proﬁling and comparison of immortalized endothelial
cells for functional genomics. Exp Cell Res 314(2):264–272
24. van der Schaft DWJ, Toebes EAH, Haseman JR, Mayo KH,
Grifﬁoen AW (2000) Bactericidal/permeability-increasing pro-
tein (BPI) inhibits angiogenesis via induction of apoptosis in
vascular endothelial cells. Blood 96(1):176–181
25. Harrington LS, Sainson RCA, Williams CK, Taylor JM, Shi W,
Li JL, Harris AL (2008) Regulation of multiple angiogenic
pathways by Dll4 and Notch in human umbilical vein endothelial
cells. Microvasc Res 75(2):144–154
26. Korff T, Augustin HG (1998) Integration of endothelial cells in
multicellular spheroids prevents apoptosis and induces differen-
tiation. J Cell Biol 143(5):1341–1352
27. Kuiper EJ, Hughes JM, Van Geest RJ, Vogels IM, Goldschme-
ding R, Van Noorden CJ, Schlingemann RO, Klaassen I (2007)
Effect of VEGF-A on expression of proﬁbrotic growth factor and
extracellular matrix genes in the retina. Invest Ophthalmol Vis
Sci 48(9):4267–4276
28. Klaassen I, Hughes JM, Vogels IM, Schalkwijk CG, Van Noor-
den CJ, Schlingemann RO (2009) Altered expression of genes
related to blood-retina barrier disruption in streptozotocin-
induced diabetes. Exp Eye Res 89(1):4–15
29. Andersen CL, Jensen JL, Orntoft TF (2004) Normalization of
real-time quantitative reverse transcription-PCR data: a model-
based variance estimation approach to identify genes suited for
normalization, applied to bladder and colon cancer data sets.
Cancer Res 64(15):5245–5250
30. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis
KJ, Scherf U, Speed TP (2003) Exploration, normalization, and
summaries of high density oligonucleotide array probe level data.
Biostatistics 4(2):249–264
31. Cui XQ, Churchill GA (2003) Statistical tests for differential
expressionincDNAmicroarrayexperiments.GenomeBiol4(4):210
32. Storey JD, Tibshirani R (2003) Statistical signiﬁcance for ge-
nomewide studies. Proc Natl Acad Sci USA 100(16):9440–9445
33. Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA
(2003) Identifying biological themes within lists of genes with
EASE. Genome Biol 4(10):R70
34. Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics
enrichment tools: paths toward the comprehensive functional
analysis of large gene lists. Nucleic Acids Res 37(1):1–13
35. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL,
Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES,
Mesirov JP (2005) Gene set enrichment analysis: a knowledge-
based approach for interpreting genome-wide expression proﬁles.
Proc Natl Acad Sci USA 102(43):15545–15550
36. Stap J, Krawczyk PM, Van Oven CH, Barendsen GW, Essers J,
Kanaar R, Aten JA (2008) Induction of linear tracks of DNA
double-strand breaks by alpha-particle irradiation of cells. Nat
Methods 5(3):261–266
37. Jakobsson L, Franco CA, Bentley K, Collins RT, Ponsioen B,
Aspalter IM, Rosewell I, Busse M, Thurston G, Medvinsky A,
Schulte-Merker S, Gerhardt H (2010) Endothelial cells dynami-
cally compete for the tip cell position during angiogenic sprout-
ing. Nat Cell Biol 12(10):943–953
38. Witmer AN, van Blijswijk BC, Van Noorden CJ, Vrensen GF,
Schlingemann RO (2004) In vivo angiogenic phenotype of
endothelial cells and pericytes induced by vascular endothelial
growth factor-A. J Histochem Cytochem 52(1):39–52
39. Sainson RCA, Johnston DA, Chu HC, Holderﬁeld MT, Nakatsu
MN, Crampton SP, Davis J, Conn E, Hughes CCW (2008) TNF
primes endothelial cells for angiogenic sprouting by inducing a
tip cell phenotype. Blood 111(10):4997–5007
40. Korff T, Augustin HG (1999) Tensional forces in ﬁbrillar
extracellular matrices control directional capillary sprouting.
J Cell Sci 112(19):3249–3258
41. Barendsz-Janson AF, Grifﬁoen AW, Muller AD, van Dam-Mi-
eras MCE, Hillen HFP (1998) In vitro tumor angiogenesis assays:
162 Angiogenesis (2012) 15:151–163
123plasminogen lysine binding site 1 inhibits in vitro tumor-induced
angiogenesis. J Vasc Res 35(2):109–114
42. Witmer AN, van Blijswijk BC, Dai J, Hofman P, Partanen TA,
Vrensen GFJM, Schlingemann RO (2001) VEGFR3 in adult
angiogenesis. J Pathol 195(4):490–497
43. Lu XW, le Noble F, Yuan L, Jiang QJ, de Lafarge B, Sugiyama
D, Breant C, Claes F, De Smet F, Thomas JL, Autiero M, Car-
meliet P, Tessier-Lavigne M, Eichmann A (2004) The netrin
receptor UNC5B mediates guidance events controlling morpho-
genesis of the vascular system. Nature 432(7014):179–186
44. Koch AW, Mathivet T, Larrivee B, Tong RK, Kowalski J, Pib-
ouin-Fragner L, Bouvre ´e K, Stawicki S, Nicholes K, Rathore N,
Scales SJ, Luis E, del Toro R, Freitas C, Breant C, Michaud A,
Corvol P, Thomas JL, Wu Y, Peale F, Watts RJ, Tessier-Lavigne
M, Bagri A, Eichmann A (2011) Robo4 maintains vessel integrity
and inhibits angiogenesis by interacting with UNC5B. Dev Cell
20(1):33–46
45. Martyn U, Schulte-Merker S (2004) Zebraﬁsh neuropilins are
differentially expressed and interact with vascular endothelial
growth factor during embryonic vascular development. Dev Dyn
231(1):33–42
46. Gerhardt H, Ruhrberg C, Abramsson A, Fujisawa H, Shima D,
Betsholtz C (2004) Neuropilin-1 is required for endothelial tip
cell guidance in the developing central nervous system. Dev Dyn
231(3):503–509
47. Strilic B, Kucera T, Eglinger J, Hughes MR, McNagny KM,
Tsukita S, Dejana E, Ferrara N, Lammert E (2009) The molecular
basis of vascular lumen formation in the developing mouse aorta.
Dev Cell 17(4):505–515
Angiogenesis (2012) 15:151–163 163
123